Veeva China Commercial & Medical Summit

With the COVID-19 pandemic continues to go back and forth, geopolitical changes, continuous optimization of data security policies, and the eighth VBP is on the line, sustainable development is becoming more and more important…Under the superposition of multiple uncertainties, pharmaceutical companies are pushing themselves to accelerate the pace of digital transformation. Whether driven by external compliance policy or internal cost reduction and efficiency improvement, digital transformation is the inevitable destination of pharmaceutical commercialization for pharmaceutical enterprises. However, while digital transformation helps pharmaceutical companies accelerate commercialization and solve business challenges, it also brings some new challenges…Charles Darwin once said that in the long history of nature, It is not the strongest of the species that survives, nor the most intelligent, but the one most responsive to change. Furthermore, facing the innovation and transformation of the internal and external environment of the market, how can pharmaceutical companies embrace changes in the digital transformation experience, find certainty from uncertainty, seize opportunities and shape the future?

新冠疫情反复，地缘政治变化，数据安全政策持续优化，第八次集采箭在弦上，可持续发展愈加重要……在多重不确定性因素的叠加下，药企正在鞭策自我，加速数字化转型的步伐。无论是迫于外部的政策合规压力，还是内部降本增效的驱动，对于制药企业而言，数字化转型都是医药营销的不二归宿。当然，数字化转型在帮助药企加速商业化和解决营销难题的同时，也产生一些新的挑战……达尔文曾经说过：在大自然的历史长河中，能够存活下来的物种，既不是那些最强壮的，也不是那些智力最高的，而是那些最能适应环境变化的。面对医药市场内外部环境的革新转变，药企如何在数字化转型历练中拥抱变化，从不确定中找到确定性，抢占先机，制胜未来？

“Embrace the change, shape the future ” —2022 Veeva China Commercial & Medical Summit will be held on 18th Oct. Looking forward to seeing you face to face as we come together to learn, share, and connect.

“拥抱变化，智胜V来 ”——2022 Veeva中国商务及医学峰会即将开幕。我们诚邀广大医药界人士共聚一堂，探讨医药数字化转型中的变与不变，以及共商应对变化的“智胜”之道。